Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 5, 2008, Pages

  Tourkina, Elena ^a,b   Richard, Mathieu ^a   Gööz, Pal ^a   Bonner, Michael ^a   Pannu, Jaspreet ^a   Harley, Russell ^b   Bernatchez, Pascal N ^c   Sessa, William C ^d   Silver, Richard M ^a   Hoffman, Stanley ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

smooth muscle actin; Collagen; Scleroderma; Tenascin C

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; CAVEOLIN 1; COLLAGEN; TENASCIN; ACTIN; CAV1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LUNG FIBROBLAST; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SCLERODERMA; ANIMAL; CELL CULTURE; DISEASE MODEL; EDITORIAL; FEMALE; FIBROBLAST; FIBROSIS; GENETICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTERSTITIAL LUNG DISEASE; LUNG; METABOLISM; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS;

ACTINS; ANIMALS; APOPTOSIS; CAVEOLIN 1; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED STRAINS; PEPTIDE FRAGMENTS; SCLERODERMA, SYSTEMIC; TENASCIN;

EID: 45849084990     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00295.2007     Document Type: Article

References (63)

1. Anderson RG. The caveolae membrane system. Annu Rev Biochem 67: 199-225, 1998.
2. Bellini A, Mattoli S. The role of the fibrocytes, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibrosis. Lab Invest 87: 858-870, 2007.
3. Beon M, Harley RA, Wessels A, Silver RM, Ludwicka-Bradley A. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clin Exp Rheumatol 22: 733-742, 2004.
4. Bernatchez P, Bauer P, Yu J, Prendergast J, He P, Sessa W. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc Natl Acad Sci USA 102: 761-766, 2005.
5. Bogatkevich GS, Tourkina E, Silver RM, Ludwicka-Bradley A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem 276: 45184-45192, 2001.
6. Bogatkevich G, Tourkina E, Abrams CS, Harley RA, Silver RM, Ludwicka-Bradley A. Contractile activity and smooth muscle-α actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol 285: L334-L343, 2003.
7. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6: 1362-1367, 2000.
8. Cantrell DA. Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114: 1439-1445, 2001.
9. Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 274: 8858-8864, 1999.
10. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de Souza A, Kitsis RN, Russell RG, Weiss LM. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 284: C457-C474, 2003.
11. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272: 6525-6533, 1997.
12. Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272: 30429-30438, 1997.
13. Cui J, Holgado-Magruda M, Su W, Tsuiki H, Wedegaertner P, Wong AJ. Identification of specific domain responsible for JNK2α2 autophosphorylation. J Biol Chem 280: 9913-9920, 2005.
14. Drab M, Vercade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
15. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428: 205-211, 1998.
16. Finch WR, Rodnan GP, Buckingham RB, Prince RK, Winkelstein A. Bleomycin-induced scleroderma. J Rheumatol 7: 651-659, 1980.
17. Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer J, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA 95: 10257-10262, 1998.
18. Gray AJ, Bishop JE, Reeves JT, Mecham RP, Laurent GJ. Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Respir Cell Mol Biol 12: 684-690, 1995.
19. Hong KM, Belperio JB, Keane MP, Burdick MD, Strieter RM. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferators activated receptor-gamma. J Biol Chem 282: 22910-22920, 2007.
20. Hua H, Munk S, Whiteside CI. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol 284: F303-F312, 2003.
21. Kang HR, Lee CG, Homer RJ, Elias JA. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med 204: 1083-1093, 2007.
22. Kasper M, Reimann T, Hempe U, Wenze KW, Bierhaus A, Schuh D, Dimmer V, Haroske G, Muller M. Loss of caveolin-1 expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol 109: 41-48, 1998.
23. Kim KK, Kudler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman NA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103: 13180-13185, 2006.
24. Li X, Rayford H, Shu R, Zhuang J, Uhal BD. Essential role for cathepsin D in bleomycin-induced apoptosis of alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 287: L46-L51, 2004.
25. Lisanti M, Scherer P, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook R, Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Biol Chem 126: 111-126, 1994.
26. Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem 277: 41295-41298, 2002.
27. Majone F, Cozzi F, Tonello M, Olivieri S, Montaldi A, Favaro M, Visentin S, Luisetto R, Ruffatti A. Unstabilized DNA breaks in lymphocytes of patients with different subsets of systemic sclerosis. Ann NY Acad Sci 1108: 240-248, 2007.
28. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasrs. J Invest Dermatol 124: 886-892, 2005.
29. Moore BB, Kolodsick JE, Thanninckal VJ, Cooke K, Moore TA, Hogaboam C, Wilke CA, Toews GB. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166: 675-684, 2005.
30. Oka N, Yamamoto M, Schwencke C, Kawabe JI, Ebina T, Ohno S, Couet J, Lisanti MP, Ishikawa Y. Caveolin interaction with protein kinase C. J Biol Chem 272: 33416-33421, 1997.
31. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing 'pre-assembled signaling complexes' at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
32. Pannu J, Nakerakanti S, Smith E, Dijke P, Trojanowska M. Transforming growth factor-β receptor type I-dependent fibrogenic gene programIs mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem 282: 10405-10413, 2007.
33. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114: 438-446, 2004.
34. Quan TE, Cowper SE, Bucala R. The role of the circulating fibrocytes in fibrosis. Curr Rheumatol Rep 8: 145-150, 2006.
35. Razani B, Rubin CS, Lisanti MP. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalitic subutit of protein kinase A. J Biol Chem 274: 26353-26360, 1999.
36. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russel RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
37. Razani B, Woodman S, Lisanti M. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
38. Rybin VO, Xu X, Steinberg SF. Activated protein kinase C isoforms target to cardiomyocyte caviolae: stimulation of local protein phosphorylation. Circ Res 84: 980-988, 1999.
39. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoformspecific monoclonal antibody probe. J Biol Chem 270: 16395-16401, 1995.
40. Sedding DG, Hermsen J, Seay U, Eickelberg O, Kummer W, Schwencke C, Strasser RH, Tillmanns H, Braun-Dullaeus RC. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res 96: 635-642, 2005.
41. Shaul P, Anderson R. Role of plasmalemmal caveolae in signal transduction. Am J Physiol Lung Cell Mol Physiol 275: L843-L851, 1998.
42. Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, Pearson JD, Dashwood M, duBois RM, Black CM, Leask A, Abraham DJ. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/PI3 kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15: 2707-2719, 2004.
43. Shi-Wen X, Rodríguez-Pascual F, Lamas S, Holmes A, Howat S, Pearson JP, Dashwood MR, du Bois RM, Denton CP, Black CM, Abraham DJ, Leask A. Constitutive ALK5-independent c-Jun N-Terminal Kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cell Biol 26: 5518-5527, 2006.
44. Song KS, Li S, Okamoto T, Guilliam LA, Sargiacomo M, Lisanti MP. Co-precipitation and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J Biol Chem 271: 9690-9697, 1996.
45. Sowa G, Pypaert M, Sessa W. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 98: 14072-14077, 2001.
46. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis. Ann Rheum Dis 66: 940-944, 2007.
47. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354: 2655-2666, 2006.
48. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, Thomas PE. Myofibroblast differentiation by transforming growth factor-beta 1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 278: 12384-12389, 2003.
49. Toker A, Newton A. Akt/protein kinase B regulated by autophosphorylation in the hypothetical PDK-2 site. J Biol Chem 275: 8271-8274, 2000.
50. Tourkina E, Hoffman S, Fenton JWII, Silver RM, Ludwicka-Bradley A. Depletion of PKC-epsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression. Arthritis Rheum 44: 1370-1381, 2001.
51. Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, Hoffman S. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase Ce. Am J Respir Cell Mol Biol 31: 28-35, 2004.
52. Tourkina E, Gooz P, Pannu J, Bonner M, Scholz D, Hacker S, Silver RM, Trojanowska M, Hoffman S. Opposing effects of protein kinase C alpha and protein kinase C epsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J Biol Chem 280: 13879-13887, 2005.
53. Tourkina E, Richard M, Charles K, Silver RM, Hoffman S. Caveolin-1 regulates collagen expression through MEK/ERK signaling and differentiation normal lung fibroblasts in myofibroblasts (Abstract). ASCB Meeting, Washington, DC, Dec. 2005.
54. Tourkina E, Richard M, Bonner M, Silver RM, Hoffman S. Anti-fibrotic and anti-inflammatory roles of caveolin-1 in scleroderma (Abstract). ASCB Meeting, San Diego, Dec. 2006.
55. Uhal B, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol Lung Cell Mol Physiol 275: L1192-L1199, 1998.
56. Van de Water J, Jiminez SA, Gershwin ME. Animal models of scleroderma: contrasts and comparisons. Int Rev Immunol 12: 201-216, 1995.
57. Vyalov SL, Gabbiani G, Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 143: 1754-1765, 1993.
58. Wang XM, Kim HP, Song R, Choi AM. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. Am J Respir Cell Mol Biol 34: 434-442, 2006.
59. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, Liu F, Ifedigbo E, Xu X, Oury TD, Kaminski N, Choi AM. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203: 2895-2906, 2006.
60. White ES, Atrasz RG, Hu B, Phan SH, Stambolic V, Mac TW, Hogaboam CM, Flaherty KR, Martinez FJ, Kontos CD, Toews GB. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog deleted on chromosome 10). Am J Respir Crit Care Med 173: 112-121.
61. Wu Z, Yang L, Cai L, Zhang M, Cheng X, Yang X, Xu J. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res 8: 1, 2007.
62. Yamamoto T, Takagawa S, Katayama I, Yamazaki Y, Shinkai H, Nashioka K. Animal model of sclerotic skin I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 112: 456-462, 1999.
63. Zhang H, Gharaee-Kermani M, Zhang K, Karmiol S, Phan SH. Lung fibrosis, alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 148: 527-537, 1996.